학술논문
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial
Document Type
Article
Author
Opal, S.M.; Laterre, P.-F.; Wittebole, X.; Francois, B.; LaRosa, S.P.; Angus, D.C.; Mira, J.-P.; Dugernier, T.; Perrotin, D.; Tidswell, M.; Jauregui, L.; Krell, K.; Pachl, J.; Peckelsen, T.T.C.; Cordasco, E.; Chang, C.-S.; Oeyen, S.; Aikawa, N.; Maruyama, T.; Schein, R.; Kalil, A.C.; Van Nuffelen, M.; Lynn, M.; Rossignol, D.P.; Gogate, J.; Wheeler, J.L.; Roberts, M.B.; Vincent, J.-L.
Source
In: JAMA . (JAMA, 20 March 2013, 309(11):1154-1162)
Subject
Language
English
ISSN
15383598
00987484
00987484